Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants

Abstract

The emergence of successive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) during 2020 to 2022, each exhibiting increased epidemic growth relative to earlier circulating variants, has created a need to understand the drivers of such growth. However, both pathogen biology and changing host characteristics—such as varying levels of immunity—can combine to influence replication and transmission of SARS-CoV-2 within and between hosts. Disentangling the role of variant and host in individual-level viral shedding of VOCs is essential to inform Coronavirus Disease 2019 (COVID-19) planning and response and interpret past epidemic trends. Using data from a prospective observational cohort study of healthy adult volunteers undergoing weekly occupational health PCR screening, we developed a Bayesian hierarchical model to reconstruct individual-level viral kinetics and estimate how different factors shaped viral dynamics, measured by PCR cycle threshold (Ct) values over time. Jointly accounting for both interindividual variation in Ct values and complex host characteristics—such as vaccination status, exposure history, and age—we found that age and number of prior exposures had a strong influence on peak viral replication. Older individuals and those who had at least 5 prior antigen exposures to vaccination and/or infection typically had much lower levels of shedding. Moreover, we found evidence of a correlation between the speed of early shedding and duration of incubation period when comparing different VOCs and age groups. Our findings illustrate the value of linking information on participant characteristics, symptom profile and infecting variant with prospective PCR sampling, and the importance of accounting for increasingly complex population exposure landscapes when analysing the viral kinetics of VOCs. Trial Registration: The Legacy study is a prospective observational cohort study of healthy adult volunteers undergoing weekly occupational health PCR screening for SARS-CoV-2 at University College London Hospitals or at the Francis Crick Institute (NCT04750356) (22,23). The Legacy study was approved by London Camden and Kings Cross Health Research Authority Research and Ethics committee (IRAS number 286469). The Legacy study was approved by London Camden and Kings Cross Health Research Authority Research and Ethics committee (IRAS number 286469) and is sponsored by University College London Hospitals. Written consent was given by all participants.

Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections

“…This preference could be associated with specific mutations which may have causal effects on intracellular viral replication dynamics in different host cell types. Recent studies indicated that BA.2 infections were characterized by a higher peak viral load, as shown in [39–41]. This is consistent with our analysis, where we found that SNPs associated with an increase in viral copies were linked to BA.2 infections.…”

Differences in virus and immune dynamics for SARS-CoV-2 Delta and Omicron infections by age and vaccination histories

“…As such, their results compare viral load measurements for Delta and Omicron infections regardless of date of symptom onset, with measurements likely to have been taken at different timepoints of individual virus dynamics trajectories. A recent study of Delta and Omicron viral kinetics accounting for time since last infection or vaccination reported higher peak viral loads for Delta infections compared to Omicron (BA.1), similar to our results [ 49 ].…”

SARS-CoV-2 epidemiology, kinetics, and evolution: a narrative review

“…By accessing these large databases, it was possible to identify individuals tested multiple times and generate longitudinal follow-ups with less accuracy than the NBA one but covering a more general population. One of the outcomes of these population follow-ups was the dierence in virus kinetics between variants [154,155]. These results should be handled with care, especially when comparing studies, because contrarily to HIV where the virus load can be estimated carefully, in the case of SARS-CoV-2 the volume sampled is highly variable and the specicities of the virus life cycle, e.g.…”